Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price traded down 2.5% on Friday . The stock traded as low as $1.73 and last traded at $1.74. 4,581,489 shares were traded during mid-day trading, a decline of 82% from the average session volume of 24,963,607 shares. The stock had previously closed at $1.78.
Tilray Stock Down 3.5 %
The stock’s fifty day moving average is $1.82 and its two-hundred day moving average is $1.87. The stock has a market capitalization of $1.45 billion, a P/E ratio of -3.94 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42.
Tilray (NASDAQ:TLRY – Get Free Report) last released its earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business had revenue of $229.90 million during the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter in the previous year, the company earned ($0.15) EPS. Tilray’s revenue for the quarter was up 24.8% on a year-over-year basis. As a group, research analysts predict that Tilray Inc will post -0.16 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Stories
- Five stocks we like better than Tilray
- Conference Calls and Individual Investors
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What Are Dividend Champions? How to Invest in the Champions
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What is the Shanghai Stock Exchange Composite Index?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.